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ABSTRACT 
The development of wound management protocols and guidelines such as the T.I.M.E. acronym are 
useful tools to aid wound care practitioners deliver effective wound care. The T.I.M.E. framework 
provides a systematic approach for the assessment and management of the majority of acute and 
chronic wounds. The debridement of devitalised tissue from the wound bed, the reduction in wound 
bioburden and effective management of wound exudate – i.e., wound bed preparation – are barriers 
to wound healing progression that are targeted by T.I.M.E. There are a large number of wound 
dressings available to experienced wound care practitioners to aid in their goal of healing wounds. 
Despite the systematic approach of T.I.M.E., the large number of wound dressings available can 
introduce a level of confusion when dressing choices need to be made. Any simplification in dressing 
choice, for example by choosing a dressing system comprising of a limited number of dressings that 
are able to address all aspects of T.I.M.E., would be a valuable resource for delivering effective 
wound care. This article reviews briefly the principles of T.I.M.E. and describes the evidence for the 
use of a two-dressing, moisture balance-oriented dressing-based wound management system for 
the treatment of wounds and that addresses principle requirements of delivering T.I.M.E. 
  
Chronic wounds present a challenge to wound care practitioners. Normal wound healing is a 
complex process that relies on the progression of a series of interdependent phases that repairs 
tissue damage and, ideally, returns structure and function to the tissue defect. Unlike acute wounds, 
chronic wounds have impaired healing responses, where they appear to have become stuck in the 
inflammatory phase of the healing response.1 The challenge faced by clinicians is to ‘convert’ these 
chronic wounds into healing wounds by resolving the signals responsible for the delayed healing 
profile and stimulating/optimising the healing response. 
Alongside a better understanding of the mechanisms responsible for delayed wound healing in 
ulcers (e.g., leg ulcers, pressure ulcers), advanced wound dressings have been developed – based 
upon an improving understanding of healing – that are designed to support the healing of chronic 
wounds.2 These wound dressings allow for optimal moisture balance at all stages of the healing 
process.   The establishment of a moist wound healing environment is known to promote effective 
healing.3,4 Wound bed preparation5 is a necessary early step in wound care as it prepares the wound 
tissue for subsequent healing; this tissue preparation is supported by  advanced wound dressings 
that promote a moist healing environment and autolytic debridement. 
The development of wound management protocols such as T.I.M.E. (an acronym for a process of 
achieving wound bed preparation) aides wound care providers by detailing a practical guide for use 
when treating patients with problematic wounds.6 Advanced wound dressings play a major role in 
delivering effective wound care within the T.I.M.E. framework. However, there are a large number of 
dressings available and it can be difficult for practitioners to identify which dressings are appropriate 
to promote which part of the healing response. This is in part due to the observation that there is 
“no single dressing suitable for the management of all wounds, and there are few dressings that are 
ideally suited for the treatment of a single wound during all stages of the healing process” (p66).7 
This article briefly reviews the T.I.M.E. framework highlighting a dressing wound management 
system that focuses on delivering optimal moisture balance across all phases of healing while 
delivering  benefits of the T.I.M.E. framework. 
T.I.M.E. WOUND MANAGEMENT 
Wound care has advanced at a rapid pace in recent years. Advanced wound dressings and updated 
wound care guidelines are designed to assist healthcare practitioners in ensuring that optimal 
treatment is used for the wide range of wounds encountered. Since its introduction in 2002, the 
T.I.M.E  framework has played an important role in aiding wound care practitioners to promote 
effective wound healing.6,8 Figure 1 summarises the sections of the T.I.M.E framework. 
T: Tissue Management – wound bed preparation & removal of devitalised tissue 
Wound bed preparation is vital to progressing a difficult-to-heal wound on the path to healing. The 
presence of devitalised tissue (e.g., necrosis and/or slough) is a barrier to healing responses and is a 
focus for bacterial growth and potential infection. Devitalised wound tissue also contributes to the 
heightened inflammatory status of these wounds.9 In addition, the presence of devitalised tissue 
over the wound also obscures the wound bed from clinical assessment and its removal is required. 
Debridement of these wounds is necessary for the restoration of a viable wound bed for wound 
healing support.9,10 
I: Infection control & Inflammation – reduce bacterial load & minimise inflammation 
High levels of wound bacteria and uncontrolled inflammation are detrimental to wound healing. The 
host defence mechanisms of patients with chronic wounds are often compromised and results in 
these patients being more prone to wound infections.9 As a consequence of wound infection, 
wounds may take longer to heal than expected.11–13 Although critical for a healing wound, when the 
inflammatory response becomes elevated and sustained (as it does in chronic wounds), a delay in 
wound healing may be witnessed. There may be  elevated inflammation due to high levels of wound 
bacteria and the high inflammatory status of chronic wounds due to the underlying wound 
aetiology14 may have a negative impact on wound healing progression. Advanced wound dressings 
are one option for influencing infection control and inflammation, acting as barriers to wound 
contamination while  maintaining a clean wound environment via cleansing some wound dressings 
will  include antibacterial agents.15 
M: Moisture balance – exudate management & optimise hydration environment 
Through all phases of normal wound healing, moisture levels are balanced and maintained to 
optimise the healing response.16 In chronic wounds, however, the disruption of the normal healing 
response results in a disturbance in hydration levels; for example, elevated levels of chronic wound 
exudate leads to problems.17 Studies have identified that elevated hydration levels, per se, are not 
damaging and have demonstrated  the benefits of a moist wound healing environment.3,4,18 As 
mentioned above, elevated chronic wound tissue-based inflammation leads to high levels of 
damaging exudate components (e.g., proteinases) that can damage the wound bed and peri-wound 
skin if not effectively managed, leading to delayed healing.16,19,20 Advanced wound dressings must 
balance moisture levels such that wounds are hydrated enough to promote a moist environment but 
tissues are not exposed to the elevated level of damaging components as discussed by Junker et al.,3 
Ousey et al.,4 and Rippon et al..18 
E: Optimisation of wound Edge – promotion of epithelialisation 
When there is a lack of epidermal closure of a wound the wound bed and peri-wound skin must be 
optimised in order for healing opportunity to be maximised. Consideration of ‘T’, ‘I’ and ‘M’ parts of 
the T.I.M.E. framework must be completed.9 Peri-wound epidermal cells are ‘primed’ to migrate 
across the wound bed21 remove devitalised tissue from the wound bed (‘T’). The modulation of 
wound bioburden and wound/peri-wound inflammatory status to pro-healing levels (‘I’ and ‘M’) and 
the establishment of a moist healing environment (‘M’) provides an optimised environment for 
wound coverage to progress. 
 
Implementation of each of the four steps of T.I.M.E. (or similar frameworks, such as the US Wound 
Registry’s D.I.M.E. (Debridement/devitalised tissue, Infection or inflammation, Moisture balance and 
wound Edge preparation/wound depth)22), can involve many different pathways and processes and 
a large number of wound dressings and products. For example, the treatment of a chronic wound 
can involve the use of a specific wound care product to promote wound debridement/removal of 
devitalised tissues such as necrosis and slough to prepare the wound bed, followed by  application of 
a dressing to control infection/inflammation (with application of other products as necessary) and 
finally use of a secondary dressing for moisture control.  
If active encouragement of epithelialisation is needed, another dressing may need to be applied. It is 
apparent that there are a plethora of products available to choose when managing  a wound 
through the various stages of healing. Tissue viability teams   need to fully understand the complex 
nature of the wound healing trajectory to be able to effectively identify appropriate wound care 
products.23 It can therefore be assumed that simplification of product choice could assist  
practitioners  with  implementation of the T.I.M.E. framework in the assessment and management 
of wounds would prove beneficial.  
A MOISTURE BALANCE-ORIENTATED DRESSING-BASED WOUND MANAGEMENT SYSTEM 
In an attempt to reduce the number of wound dressings required to deliver effective wound care, 
and reduce  confusion when choosing a product,24–27 a recently developed moisture balance-
oriented dressing-based wound management system has been developed. This system aims to 
simplify wound dressing choice when applying  the concept of  T.I.M.E. in the management of 
chronic wounds. It is based upon two dressings (Hydro-Responsive Wound Dressings, HRWDs) that 
complement one another, delivering  rapid cleansing, early granulation tissue formation, 
epithelialisation while maintaining a  balanced level of moisture at all phases of wound progression 
to support effective wound healing.28 A review of  laboratory and clinical evidence (see below) 
indicates that these HRWDs can implement all the steps involved in the T.I.M.E. framework (Figure 
1).  
HRWD #1: Hydro-Responsive Wound Dressing activated by Ringer’s solution 
HRWD #1 cleanses the wound by encouraging autolytic debridement of devitalised tissues present in 
the wound. The fluid handling characteristics of the dressing absorbs wound exudate and removes 
the bacteria and damaging chronic wound exudate components that can potentially affect healing 
progression.28 The high Ringer’s solution content within the core of the dressing acts as a reservoir 
for wound cleansing promotion. The high pH buffering capacity of the HRWD superabsorber 
modifies the pH of exudate with the Ringer’s solution diluting biological exudate components that 
cause wound bed damage.29 These characteristics mean that HRWD #1 can address the first three 
steps of T.I.M.E.;  cleansing the wound bed (T), removes factors involved in infection and assists with 
inflammation control (I), and provides an optimal moist wound environment (M). 
HRWD #2: Hydro-Responsive Wound Dressing with AquaClear Gel Technology 
HRWD #2 is a foam dressing that uses AquaClear Gel Technology and an active moisture-release 
system to maintain the beneficial moist environment established by HRWD #1. The AquaClear Gel 
Technology promotes effective moisture balance in the latter stages of the progressing wound whilst 
at the same time concentrating within the moist environment growth factors that help promote re-
epithelialisation.30 HRWD #2 is able to address a number of steps of T.I.M.E. The ability to maintain a 
moist wound environment allows the dressing to maintain the optimal moisture balance (M)) 
established by HRWD #1 and extend the optimal wound environment to support epithelialisation (E). 
This simple moisture balance-oriented dressing-based wound management system provides support 
for all four of the T.I.M.E. management strategy steps (Figure 2). Chronic wounds can be the most 
challenging for clinicians as by definition these are wounds that do not progress through healing in a 
timely manner.31 Chronic wounds should be carefully classified according to validated classification 
systems.32 allowing wound care practitioners to assess whether a moisture balance-oriented 
dressing-based wound management system is suitable for these wound types. 
CLINICAL EVIDENCE TO SUPPORT MOISTURE BALANCE-ORIENTED DRESSING-BASED WOUND 
MANAGEMENT SYSTEM IMPACT IN T.I.M.E. 
HRWD #1 and HRWD #2 are designed to optimise hydration levels in wounds.  Although based upon 
the core technology of superabsorbent polymers, current HRWDs have a long history in treating 
wounds. Over the course of over 20 years, modifications have led to improvements in the design of 
these HRWDs but the core technology and the mechanism of action has remained constant.4 For the 
purpose of this discussion, clinical studies based upon previous dressing iterations are included 
alongside studies conducted using the most recent versions. 
HRWD #1 and HRWD #2 offer a simple wound management regimen that provides solutions to the 
T.I.M.E. wound management framework ( Table 1). The effective removal of necrotic tissue, 
fibrinous slough and bacteria-laden wound exudates and the promotion of granulation tissue 
formation and epithelialisation using the moisture balance-oriented dressing-based wound 
management system is supported by a number of clinical studies. The following sections summarise 
some of the key clinical studies for each of the four sections of the T.I.M.E. wound management 
framework (Tables 2-5). 
T: Tissue Management – wound bed preparation & removal of devitalised tissue (Table 2) 
At the centre of tissue management is the removal of  necrotic or compromised tissue that is 
commonly present in chronic wounds.33 Acting as a barrier to re-epithelialisation and as a potential 
reservoir for bacterial growth and possible infection, the removal of this devitalised tissue is the first 
step in ‘kick-starting’ these chronic wounds along the pathway of healing. Hydro-responsive wound 
dressings, are important tools in preparing  wound beds by promoting autolytic debridement. 
Data from a number of clinical studies and additional case studies (Table 2) suggests that dressings 
of the moisture balance-oriented dressing-based wound management portfolio are associated with 
a significant reduction in necrotic and devitalised tissues (including slough)  including venous leg 
ulcers, diabetic foot ulcers and pressure ulcers.. The promotion of  autolytic debridement of 
fibrinous slough and necrotic tissue results in a reduction in the proportion of the wound bed 
covered by devitalised tissue and a corresponding increase on the presence of granulation tissue. 
Observational studies where HRWD #1 was applied to wounds partially and/or significantly covered 
by devitalised tissue, resulted in significant removal of necrotic/sloughy tissue.34–37 In one particular 
study, a multi-centre, open, prospective and randomised two-arm study comparing HRWD with an 
amorphous gel treatment in venous leg ulcer patients; the hydro-responsive wound dressings 
resulted in a rapid debridement of these wounds and a more effective promotion of autolytic 
debridement compared with the amorphous gel preparation.38 
A significant number of additional studies, including case series studies and case studies (Table 1), all 
indicate that moisture balance-oriented dressing-based wound management system treatment 
results in the removal of devitalised tissue from wounds of varying aetiologies. 
The cleansing action of HRWD #1 promotes the removal of devitalised tissue through the 
enhancement of autolytic debridement of the wound. Debridement, together with the increase in 
healthy granulation tissue prepares the wound bed for subsequent healing. 
I: Infection control & Inflammation – reduce bacterial load & minimise inflammation (Table 3) 
As well as the underlying disease processes that may result in the formation and maintenance of 
chronic wounds leading to tissue inflammation, the presence of elevated levels of bacterial 
contamination may also contribute to the stimulation of a localised inflammatory response in the 
wound bed adjacent to any devitalised tissues. The presence of the bacteria themselves may 
stimulate inflammation but bacterial toxins, including bacterial proteinases, also contribute to this 
inflammatory stimulus. HRWDs, with their novel fluid management capabilities, offer the capability 
to reduce wound bioburden39,40 and local tissue inflammatory stimuli,41 and by modulating the local 
wound environment via affecting the “I” section of the T.I.M.E. framework. 
Data from three open, prospective, observational studies where one clinical outcome was changes in 
clinical signs of infection all show reduced evidence of wound infection when treated with HRWDs ( 
Table 3). Clinical studies of patients with variety of chronic wounds including venous leg ulcers, 
diabetic foot ulcers and pressure ulcers treated with HRWDs consistently showed a reduction in the 
number of wounds exhibiting  clinical signs of infection. Laboratory studies examining the interaction 
between these dressings and micro-organisms suggest that HRWDs have the ability to absorb and 
retain significant numbers of micro-organisms either when these organisms are in suspension or 
presented to the dressing as an agar-covering mat.39,40 
As well as the presence of elevated levels of bacteria in the wound bed, the presence of elevated 
levels of protein-degrading enzymes (from both bacterial contamination sources and from tissue-
derived inflammatory cells) will potentiate local inflammation levels. Modulation of proteinase 
activity levels in and around the wound is likely to reduce the level of inflammatory stimuli 
experienced by the tissue. Studies examining the interaction between matrix metalloproteinases 
(MMPs) and the superabsorbent particles (SAPs) contained within moisture balance-oriented 
dressing-based wound management system dressings have indicated a significant effect on 
proteinase activities.41 The SAPs contained within these dressings inhibited MMP activity from 
wound fluid from chronic venous leg ulcers by >87%. Interestingly, MMPs were inhibited via two 
mechanisms: 1) direct binding of MMPs by dressing materials, and 2) binding of co-factors necessary 
for MMP activity. The effective binding of proteinases by these dressings is likely to reduce the 
inflammatory stimuli affecting chronic wounds and its surroundings. 
Cleansing  the wound bed of devitalised tissue (necrotic and/or slough) by HRWD #1 reduces the 
wound’s bacterial load via effective absorption and retention of micro-organisms. This action, 
together with the dressing’s ability to retain damaging and irritant wound-derived components such 
as proteinases (MMPs), reduces and minimises additional inflammatory stimulus that is likely to be 
harmful to wound healing progression. 
M: Moisture balance – exudate management & optimise hydration environment (Table 4) 
Balancing skin hydration levels is important for the normal functioning of this important organ and 
disruption of moisture levels when skin wounding occurs upsets this fine balance.28 Re-optimising  
moisture balance is a key requirement for the tissue and  appropriate dressing choice is key to aiding 
wound management. HRWDs, with their innovative fluid absorption/moisture release ‘pre-activated’ 
superabsorbent technology, are important tools for balancing the moisture levels necessary for 
optimal healing.4 The absorbing and rinsing effect, as well as the absorption of protein- and bacteria-
laden wound exudate, have been demonstrated in laboratory studies.42 As well as donating pre-
absorbed Ringer’s solution to its surroundings, the wound dressing is capable of absorbing and 
binding proteins and bacteria as fluid is absorbed into the dressing pad. These laboratory studies 
offer an insight into the mechanism by which moisture balance-oriented dressing-based wound 
management system aids absorption of exudate and provide good exudate management. 
Data from a number of clinical studies offer evidence of the excellent moisture management 
capabilities of the HRWDs (Table 4). When questioned about effectiveness of HRWDs in the 
management of wound exudate during the treatment of chronic wounds, clinicians responded  
positively and expressed satisfaction with the moisture absorption and retention capacity of 
HRWDs.35–37 The balancing of moisture levels in and around the wound by HRWDs translated to 
improvements in the peri-wound skin of chronic wound patients: use of HRWD led to a reduction in 
peri-wound skin irritation.37 
A number of clinical studies have shown improvements in peri-ulcer skin condition, an indication of 
effective exudate management and the optimisation of hydration levels in and around the wound. 
Two large observational studies where HWRD and HRWD #2 (with AquaClear Gel Technology) was 
used to treat a number of difficult-to-heal wounds with a variety of aetiologies (e.g., VLU, diabetic 
foot, pressure ulcer, burns) showed significant improvements in peri-wound skin conditions when 
treated with HRWDs.37,43 Additional case study reports also provide evidence for the moisture 
balance-oriented dressing-based wound management system providing effective moisture balance 
control when used in the treatment of problematic wounds.44,45  
The current moisture balance-oriented dressing-based wound management system offers two 
complementary approaches to wound healing therapy. HRWD #1 debrides and cleanses wounds by 
balancing of wound environment moisture levels leading to effective wound progression through 
“T”, “I” and the “M” compartments of the T.I.M.E. framework. HRWD #2 builds on the solid 
foundation for wound progression by continuing to optimise moisture levels of the granulating 
wound in order to promote the final stages of healing. 
E: Optimisation of wound Edge – promotion of epithelialisation (Table 5) 
Wound re-epithelialisation requires a number of elements of the wound and surrounding tissue to 
be optimised for wound coverage to proceed. A healthy granulation tissue free of devitalised tissue 
is required for migrating epithelium to provide wound coverage. In addition, the peri-wound 
epidermis must be in an optimal state – e.g., minimally inflamed – for epithelial migration to 
proceed efficiently. The complimentary dressings of the moisture balance-oriented dressing-based 
wound management system promote the optimal wound base and peri-wound skin environments 
for achieving positive re-epithelialisation responses. 
For re-epithelialisation to occur the wound bed must be able to sustain epidermal migration. In 
chronic wounds, evidence suggests that the wound bed matrix is ‘immature’ in terms of its ability to 
support epidermal migration.46 The establishment of a moist wound environment and an optimal 
moisture balance of the wound that progresses the chronic wound along the healing pathway results 
in the development of healthy granulation tissue that is able to support migrating epidermis. Studies 
have shown that the epidermis at the wound margin expresses a migratory phenotype and is able to 
migrate but cannot until healthy granulation tissue is present.46 Inflamed peri-wound skin (including 
epidermis) is unlikely to be in the optimal state required for effective migration. The moisture 
balance-oriented dressing-based wound management system are able to promote the development 
of the healthy granulation tissue and optimised peri-ulcer skin necessary for effective re-
epithelialisation to occur (Table 5). 
A number of clinical studies have shown HRWDs associated with the development of healthy 
granulation tissue. Proportions of healthy granulation tissue increased significantly as a result of the 
increased debridement of devitalised necrotic and sloughy tissues covering wounds of different 
aetiologies.35,37,38,47 Together with improvements in peri-wound skin condition when wounds were 
treated with HRWDs (Table 6),35,36 the development of healthy granulation tissue corresponded with 
re-epithelialisation of chronic wounds37,47,48 and an increase in the number of chronic wounds 
progressing to healing.36 
In vitro studies have suggested that the HRWD #2’s moisture management system, AquaClear Gel 
Technology, may influence epidermal migration directly and complement the beneficial moisture 
balance effects of HRWD #2 and HRWD #1. HRWD #2’s hydrated polyurethanes have been shown to 
concentrate proteins from complex solutions.49 When exposed to these hydrated polyurethanes, 
platelet releasate growth factor activity is increased (as measured by keratinocyte cell growth). 
Supplementary experiments showed a concentration of epidermal growth factors (e.g., hepatocyte 
growth factor) and the stimulation of epidermal cell migration, as measured by enhanced closure of 
an in vitro scratch wounding model.30 A 270-patient prospective, observational study of the 
treatment of a variety of granulating chronic wounds with HRWD #2 showed a reduction in per-
lesional skin irritation and an accompanying increase in the proportion of wound epithelialisation.43 
A number of clinical case studies also reported re-epithelialisation of wounds treated with HRWD 
(Table 1 ). 
The combination of the complimentary benefits of HRWD #1 and HRWD #2 leads to the optimisation 
of the wound bed granulation tissue and to the peri-wound skin and maximises the opportunity for 
wound re-epithelialisation and closure of the tissue defect. Figure 3 highlights a number of clinical 
examples where the two-dressing, moisture balance-oriented dressing-based wound management 
system has been used effectively in the treatment of wounds with a variety of aetiologies. 
CONCLUSION 
Modern wound care has a myriad of wounds dressings (traditional and advanced) that aid wound 
care practitioners deliver effective wound care. The concept of wound bed preparation has become 
a cornerstone in the efforts to heal problematic wounds and the development of protocols such as 
T.I.M.E. provide a systematic approach for treating wounds, and the appropriate use of wound 
dressings is key to optimising wound healing treatments. The two-dressing, moisture balance-
oriented dressing-based wound management system approach to wound care offers a valuable tool 
in delivering effective wound management, simplifying which wound dressing to use from the large 
number of dressings currently available that addresses the requirements set out in T.I.M.E..  
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